High Prevalence of Polycystic Ovary Syndrome in Type 1 Diabetes Mellitus Adolescents: Is There a Difference Depending on the NIH and Rotterdam Criteria?
- PMID: 28437788
- DOI: 10.1159/000471805
High Prevalence of Polycystic Ovary Syndrome in Type 1 Diabetes Mellitus Adolescents: Is There a Difference Depending on the NIH and Rotterdam Criteria?
Abstract
Background: Polycystic ovary syndrome (PCOS) is more frequently observed in type 1 diabetes mellitus (T1DM) adult women than in nondiabetic women. No such prevalence has yet been studied in adolescent girls with T1DM.
Aim: The aim of this study was to evaluate the prevalence of PCOS in adolescent girls with T1DM and to determine the clinical and hormonal features associated with the disorder.
Methods: A cross-sectional study of 53 adolescent girls (gynecological age >2 years) referred for routine evaluation for T1DM was conducted. We diagnosed PCOS using the National Institutes of Health (NIH) and Rotterdam criteria.
Results: 26.4 and 47.9% of adolescents had PCOS according to NIH (NIH-PCOS) and Rotterdam (Rotterdam-PCOS) criteria. 66.7% of NIH-PCOS adolescents had a complete phenotype associated with hyperandrogenism, oligomenorrhea, and polycystic ovarian morphology, unlike only 33.3% of the Rotterdam-PCOS adolescents. A family history of type 2 diabetes mellitus (T2DM) was more frequent in PCOS than in non-PCOS girls, whichever criteria were used. Late pubertal development and a T1DM diagnosis close to puberty were factors associated with NIH-PCOS.
Conclusion: Adolescents with T1DM had a high prevalence of PCOS. More differences between PCOS and non-PCOS patients were found using the NIH criteria, suggesting that clinical characteristics might be more accurate for diagnosing PCOS in girls with T1DM. A family history of T2DM is associated with a high risk of PCOS.
Keywords: Adolescence; Hyperandrogenism; NIH and Rotterdam criteria; Polycystic ovary syndrome; Type 1 diabetes mellitus.
© 2017 S. Karger AG, Basel.
Similar articles
-
Prevalence of polycystic ovarian syndrome in Indian adolescents.J Pediatr Adolesc Gynecol. 2011 Aug;24(4):223-7. doi: 10.1016/j.jpag.2011.03.002. Epub 2011 May 19. J Pediatr Adolesc Gynecol. 2011. PMID: 21600812
-
The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.Clin Endocrinol (Oxf). 2008 Jul;69(1):52-60. doi: 10.1111/j.1365-2265.2007.03145.x. Epub 2008 Jul 1. Clin Endocrinol (Oxf). 2008. PMID: 18034780
-
The Influence of Prepubertal Onset of Type 1 Diabetes and Age of Menarche on Polycystic Ovary Syndrome Diagnosis.J Clin Endocrinol Metab. 2021 May 13;106(6):1811-1820. doi: 10.1210/clinem/dgab062. J Clin Endocrinol Metab. 2021. PMID: 33537700
-
Polycystic ovary syndrome: a common but often unrecognized condition.J Midwifery Womens Health. 2012 May-Jun;57(3):221-30. doi: 10.1111/j.1542-2011.2012.00161.x. J Midwifery Womens Health. 2012. PMID: 22594862 Review.
-
Polycystic Ovary Syndrome in Adolescents.Endocrinol Metab Clin North Am. 2016 Jun;45(2):329-44. doi: 10.1016/j.ecl.2016.01.004. Epub 2016 Apr 1. Endocrinol Metab Clin North Am. 2016. PMID: 27241968 Review.
Cited by
-
Prevalence of polycystic ovary syndrome and its clinical and hormonal profile in young females with type 1 diabetes mellitus: experience from a teaching institution of India.Endocrine. 2023 Nov;82(2):303-310. doi: 10.1007/s12020-023-03470-z. Epub 2023 Aug 24. Endocrine. 2023. PMID: 37615813
-
High BMI and Insulin Resistance Are Risk Factors for Spontaneous Abortion in Patients With Polycystic Ovary Syndrome Undergoing Assisted Reproductive Treatment: A Systematic Review and Meta-Analysis.Front Endocrinol (Lausanne). 2020 Dec 3;11:592495. doi: 10.3389/fendo.2020.592495. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33343510 Free PMC article.
-
Protective effects of berberine in a rat model of polycystic ovary syndrome mediated via the PI3K/AKT pathway.J Obstet Gynaecol Res. 2021 May;47(5):1789-1803. doi: 10.1111/jog.14730. Epub 2021 Mar 11. J Obstet Gynaecol Res. 2021. PMID: 33709493 Free PMC article.
-
Network pharmacology-based strategic prediction and target identification of apocarotenoids and carotenoids from standardized Kashmir saffron (Crocus sativus L.) extract against polycystic ovary syndrome.Medicine (Baltimore). 2023 Aug 11;102(32):e34514. doi: 10.1097/MD.0000000000034514. Medicine (Baltimore). 2023. PMID: 37565925 Free PMC article.
-
Autoimmunity to the Follicle-Stimulating Hormone Receptor (FSHR) and Luteinizing Hormone Receptor (LHR) in Polycystic Ovarian Syndrome.Int J Mol Sci. 2021 Dec 20;22(24):13667. doi: 10.3390/ijms222413667. Int J Mol Sci. 2021. PMID: 34948471 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical